The contraceptive efficacy of emergency contraceptive pills containing levonorgestrel (LNG-EC) has been estimated in most previous studies by judging the day of ovulation from presumptive menstrual cycle data, thus providing poorly reliable estimates.
In the present study, the efficacy of LNG-EC was determined in 393 cycles by dating ovulation on the basis of reliable hormonal and ovarian parameters validated by a database constructed in a separate study. In addition, the efficacy was determined separately for cycles in which LNG-EC was given before or after ovulation.
For the 148 women who had sexual intercourse during the fertile days, the overall accumulated probability of pregnancy was 24.7, while altogether 8 pregnancies were observed. Thus, the overall contraceptive efficacy of LNG-EC was 68%. Among the 103 women who took LNG-EC before ovulation (days ���5 to ���1), 16 pregnancies were expected and no pregnancy occurred (p<.0001). Among the 45 women who took LNG-EC on the day of ovulation (day 0) or thereafter, 8 pregnancies occurred and 8.7 were expected (p=1.00). These findings are incompatible with the inhibition of implantation by LNG-EC in women. The same cases were also analyzed using the presumptive menstrual cycle data, and important discrepancies were detected between the two methods.
The efficacy of LNG-EC has been overestimated in studies using presumptive menstrual cycle data. Our results confirm previous similar studies and demonstrate that LNG-EC does not prevent embryo implantation and therefore cannot be labeled as abortifacient.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Contraception
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation.Contraception. 2010; 81: 414-420
- Post-coital treatment with levonorgestrel does not disrupt post-fertilization events in the rat.Contraception. 2003; 67: 415-419
- Postcoital administration of levonorgestrel does not interfere with postfertilization events in the new-world monkey Cebus apella.Hum Reprod. 2004; 19: 1352-1356
- Effectiveness of levonorgestrel emergency contraception given before or after ovulation ��� a pilot study.Contraception. 2007; 75: 112-118
- Effects of oral and vaginal administration of levonorgestrel emergency contraception on markers of endometrial receptivity.Hum Reprod. 2010; 25: 874-883
- Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function.Contraception. 2004; 69: 373-377
- Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.Fertil Steril. 2009; 91: 256-264
- Ectopic pregnancy and emergency contraceptive pills: a systematic review.Obstet Gynecol. 2010; 115: 1263-1266
- Normal variation in the length of the luteal phase of the menstrual cycle: identification of the short luteal phase.Br J Obstet Gynaecol. 1984; 91: 685-689
- Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy and sex of the baby.N Engl J Med. 1995; 333: 1517-1521
- Post-ovulatory ageing of the human oocyte and embryo failure.Hum Reprod. 1998; 13: 394-397
- A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception.Hum Reprod. 1993; 8: 389-392
- Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception.Lancet. 1998; 352: 428-433
- Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial.Lancet. 2002; 360: 1803-1810
- Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians.Contraception. 2002; 66: 269-273
- Levonorgestrel and mifepristone in emergency contraception.Steroids. 2003; 68: 1107-1113
- A randomized trial of mifepristone (10 mg) and levonorgestrel for emergency contraception.Obstet Gynecol. 2004; 104: 1307-1313
- Pituitary���ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75 mg dose given on the days preceding ovulation.Contraception. 2004; 70: 442-450
- The hormonal and peripheral effects of d-norgestrel in postcoital contraception.Contraception. 1974; 10: 411-424
- In vivo assessment of the human sperm acrosome reaction and the expression of glycodelin-A in human endometrium after levonorgestrel-emergency contraceptive pill administration.Hum Reprod. 2007; 22: 2190-2195
- Time of implantation of the conceptus and loss of pregnancy.N Engl J Med. 1999; 340: 1796-1799
- On the mechanisms of action of short-term levonorgestrel administration in emergency contraception.Contraception. 2001; 4: 227-234
- A single midcycle dose of levonorgestrel similar to emergency contraceptive does not alter the expression of the l-selectin ligand or molecular markers of endometrial receptivity.Fertil Steril. 2010; 94: 1589-1594
- Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model.Hum Reprod. 2007; 22: 3031-3037
- Mechanism of action of emergency contraception.Contraception. 2010; 82: 404-409
- The role of matching menstrual data with hormonal measurements in evaluating effectiveness of postcoital contraception.Contraception. 1999; 60: 243-247
- Transvaginal ultrasonography in women receiving emergency contraception.Fertil Steril. 2003; 79: 1074-1077
Published online: April 27, 2011
Accepted: March 9, 2011
Received in revised form: March 7, 2011
Received: October 22, 2010
© 2011 Elsevier Inc. Published by Elsevier Inc. All rights reserved.